This group is for elite investors and traders that are dedicated to participating in an active community that wants to learn from each other, share their research, and work together to do deep analysis of securities. The moderator of this group taught securities analysis at UCLA and is dedicated to helping other investors improve their abilities.
In this private group, membership is restricted and regular contributions are required. Any member not contributing on a regular basis will be removed to make room for a new member.
In your application messsage, please share your background and what you can contribute to the group.
Company Overview and News
July 18 (Reuters) - Pennsylvania environmental regulators this week issued another notice of violation to Energy Transfer Partners LP's Sunoco Mariner East 2 natural gas liquids pipeline for spilling drilling fluid in a wetland.
ETP.PRC RRC ETP RGRYY RRL RRS RGRLF
(Reuters) - Pennsylvania environmental regulators this week issued another notice of violation to Energy Transfer Partners LP’s Sunoco Mariner East 2 natural gas liquids pipeline for spilling drilling fluid in a wetland.
ETP.PRC RRC ETP RGRYY RRL RRS RGRLF
July 13 (Reuters) - TransCanada Corp's Columbia Gas Transmission expects the section of the Leach Xpress natural gas pipeline damaged in a blast in West Virginia in early June to return to service on July 15.
ENBBF ETP.PRC TRP KMI.WS RRL ENB RRS RGRLF RRC ENB ETP KMI.PRA RGRYY KMI TRI EBBNF KMR CVB KMRFZ
(Reuters) - TransCanada Corp’s Columbia Gas Transmission expects the section of the Leach Xpress natural gas pipeline damaged in a blast in West Virginia in early June to return to service on July 15.
ENBBF ETP.PRC TRP KMI.WS RRL ENB RRS RGRLF RRC ENB ETP KMI.PRA RGRYY KMI EBBNF KMR CVB KMRFZ
Stocks followed through on Friday’s surprisingly bullish session, with the S&P 500 rallying another 0.88% on Monday. The index is now within reach of multimonth highs, and back within reach of the record high set back in January. Groupon (NASDAQ:GRPN) led the charge with an 11% gain on rumors that it was looking for a buyer. It was hardly alone in its bullishness though. More than 70% of stocks ended the day with a gain on Monday, and more than 80% of the market’s volume was bullish.
RRC GRPN RGRYY TWTR RRL RRS PFE SBAC RGRLF
July 2 (Reuters) - TransCanada Corp's Columbia Gas Transmission unit pushed back the date the section of its Leach Xpress natural gas pipeline in West Virginia will resume service to mid-July from an earlier forecast of early July.
RRC TRP EQM RGRYY TRI RRL RRS TEP RGRLF
June 29 (Reuters) - U.S. federal energy regulators have told Energy Transfer Partners LP to finish restoring the land around parts of its Rover natural gas pipeline in Ohio and Michigan before allowing the company to put more segments in service.
ECR RRC ETP.PRC ETP RGRYY EQT RRL AST RRS AR RGRLF ACTPF
FORT WORTH, Texas, June 29, 2018 (GLOBE NEWSWIRE) -- RANGE RESOURCES CORPORATION (NYSE:RRC) announced today that its second quarter 2018 financial results news release will be issued Monday, July 30 after the close of trading on the New York Stock Exchange.
RRC RGRYY DTK RRL RRS RGRLF
June 19 (Reuters) - TransCanada Corp’s Columbia Gas Transmission (TCO) unit has estimated that the section of the Leach Xpress natural gas pipeline, damaged in a blast on June 7 in Marshall County, West Virginia, will resume operations early in July.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY EBBNF
June 15 (Reuters) - TransCanada Corp's Columbia Gas Transmission (TCO) unit said it fixed a section of the Leach Xpress natural gas pipeline downstream of a pipe blast in West Virginia last week.
ENBBF ETP.PRC TRP RRL ENB RRS TEP RGRLF RRC ENB EQM ETP RGRYY TRI EBBNF
2018-07-17 - Asif
History and Development of the Company Kitov Pharma was incorporated under the laws of the State of Israel (under a previous name) on August 12, 1968 and its ordinary shares were originally listed for trading on the TASE in 1978. The company's ordinary shares are currently traded on the TASE under the symbol “KTOV”, and its ADSs and its public warrants are traded on NASDAQ under the symbols “KTOV” and “KTOVW”, respectively. In October 2012, the District Court in Lod, Israel approved the creditors arrangement in accordance with Section 350 of the Companies Law in order to effectuate the sale by Kitov Pharma (then known as Mainrom Line Logistics Ltd.) of all its activities, assets, rights, obligations and liabilities to a private company held by its then controlling shareholders, and all rights of Kitov Pharma’s creditors against it were extinguished. The sale was made pursuant to an arrangement between Kitov Pharma and its creditors. Following such sale and a related cash...
2018-07-17 - Asif
Overview and Recent Developments Athersys is an international biotechnology company that is focused primarily in the field of regenerative medicine. The company's MultiStem® cell therapy, a patented and proprietary allogeneic stem cell product, is its lead platform product and is currently in later-stage clinical development. The company's current clinical development programs are focused on treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, certain pulmonary conditions and other conditions where the current standard of care is limited or inadequate for many patients, particularly in the critical care segment. Current Programs By applying its proprietary MultiStem cell therapy product, the company established therapeutic product development programs treating neurological conditions, cardiovascular disease, inflammatory and immune disorders, and other conditions. The company's programs in the clinical development stage include ...
2018-07-16 - Asif
General The company's objective is to build a profitable and growing specialty therapeutics company. To meet this objective, Cytori Therapeutics has acquired and are developing two technology platforms that hold promise for treating millions of patients and represent significant potential for increasing shareholder value. The company's current corporate activities fall substantially into advancing these platforms: Cytori Nanomedicine and Cytori Cell Therapy. The Cytori Nanomedicine platform features a versatile liposomal nanoparticle technology for drug encapsulation that has thus far provided the foundation to bring two promising drugs into mid/late stage clinical trials. Nanoparticle encapsulation is promising because it can help improve the delivery and metabolism of many drugs, thus potentially enhancing the therapeutic profile and patient benefits. The company's lead drug candidate, ATI-0918 is a generic version of pegylated liposomal encapsulated doxorubicin. Pegyl...
as of ET